Showing results (21-30 of 42) with videos related to

Sort By:
Pageof 5
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|April 7, 2009
Scoring of p16(INK4a) immunohistochemistry based on independent nuclear staining alone can sufficiently distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray studyChih-Ping Han, Lai-Fong Kok, Po-Hui Wang, et al.
Virchows Archiv : an International Journal of Pathology|March 12, 2010
Distinguishing between primary endocervical and endometrial adenocarcinomas: is a 2-marker (Vim/CEA) panel enough?Chiung-Ling Liao, Jeng-Dong Hsu, Ming-Yung Lee, et al.
Reproductive Sciences (Thousand Oaks, Calif.)|April 25, 2012
Single-nucleotide polymorphisms and haplotypes of membrane type 1-matrix metalloproteinase in susceptibility and clinical significance of squamous cell neoplasia of uterine cervix in Taiwan womenYi-Torng Tee, Yu-Fan Liu, Jinghua Tsai Chang, et al.
Virchows Archiv : an International Journal of Pathology|September 19, 2009
p16 INK4 and CEA can be mutually exchanged with confidence between both relevant three-marker panels (ER/Vim/CEA and ER/Vim/p16 INK4) in distinguishing primary endometrial adenocarcinomas from endocervical adenocarcinomas in a tissue microarray studyChih-Ping Han, Ming-Yung Lee, Yeu-Sheng Tyan, et al.
Archives of Gynecology and Obstetrics|October 23, 2009
A reappraisal of three-marker (ER/Vim/CEA), four-marker (ER/Vim/CEA/PR), and five-marker (ER/Vim/CEA/PR/p16INK4a) panels in the diagnostic distinction between primary endocervical and endometrial adenocarcinomas in a tissue microarray studyChih-Ping Han, Ming-Yung Lee, Lai-Fong Kok, et al.
Archives of Gynecology and Obstetrics|May 7, 2009
Comparing the scoring mechanisms of p16INK4a immunohistochemistry based on independent nucleic stains and independent cytoplasmic stains in distinguishing between endocervical and endometrial adenocarcinomas in a tissue microarray studyLai-Fong Kok, Ming-Yung Lee, Yeu-Sheng Tyan, et al.
Taiwanese Journal of Obstetrics & Gynecology|March 11, 2026
High frequency of BRAF mutations and concomitant KRAS mutations in Taiwanese ovarian clear cell carcinomaHuang-Pin Shen, Ming-Yung Lee, Wan-Ru Chao, et al.
Annals of Surgical Oncology|February 25, 2011
Identification of the coexisting HER2 gene amplification and novel mutations in the HER2 protein-overexpressed mucinous epithelial ovarian cancerWea-Lung Lin, Wu-Hsien Kuo, Fong-Lin Chen, et al.
Archives of Gynecology and Obstetrics|May 16, 2009
Five commonly used markers (p53, TTF1, CK7, CK20, and CK34betaE12) are of no use in distinguishing between primary endocervical and endometrial adenocarcinomas in a tissue microarray extension studyChih-Ping Han, Lai-Fong Kok, Ming-Yung Lee, et al.
Journal of Translational Medicine|April 16, 2009
Scoring mechanisms of p16INK4a immunohistochemistry based on either independent nucleic stain or mixed cytoplasmic with nucleic expression can significantly signal to distinguish between endocervical and endometrial adenocarcinomas in a tissue microarray studyChiew-Loon Koo, Lai-Fong Kok, Ming-Yung Lee, et al.
Pageof 5